Soliton Inc
NASDAQ:SOLY
Intrinsic Value
Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of SOLY.
Soliton Inc's market capitalization is 487.6m USD.
SOLY stock price is 22.58 USD.
SOLY.
SOLY. Open DCF Valuation
SOLY. Open Relative Valuation
SOLY.
SOLY has positive Gross Profit for the last twelve months.
SOLY's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -985% to -1 004%, and is approaching profitability.
SOLY's ROE (Return on Equity) has significantly increased in the last 3 years from -95% to -64%, and is approaching profitability.
SOLY has negative Operating Income for the last twelve months.
SOLY has negative Net Income for the last twelve months.
SOLY's ROE (Return on Equity) for the past 12 months is negative and is equal to -64%.
SOLY's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -1 004%.
SOLY has negative Free Cash Flow for the last twelve months.
SOLY has very high three-year average ROE (Return on Equity): 68%. The company is very efficient at transforming stockholders' equity into net income.
SOLY has negative three-year average ROIC (Return on Invested Capital): -749%. The company is not efficient at using invested capital to generate operating income.
SOLY's short-term assets (23m USD) exceed its short-term liabilties (4m USD).
SOLY's long-term assets (26m USD) exceed its long-term liabilties (4m USD).
SOLY's D/E (Debt to Equity) is very low and is equal to 0.
SOLY's Altman Z-Score is very high and is equal to 55.
Fundamental Analysis
Soliton Inc
Balance Sheet Decomposition
Soliton Inc
| Current Assets | 23m |
| Cash & Short-Term Investments | 21.7m |
| Other Current Assets | 1.2m |
| Non-Current Assets | 2.6m |
| PP&E | 2.3m |
| Intangibles | 318k |
| Current Liabilities | 4.2m |
| Accounts Payable | 671k |
| Accrued Liabilities | 3.5m |
Earnings Waterfall
Soliton Inc
|
Revenue
|
370k
USD
|
|
Cost of Revenue
|
-344k
USD
|
|
Gross Profit
|
26k
USD
|
|
Operating Expenses
|
-23.8m
USD
|
|
Operating Income
|
-23.8m
USD
|
|
Other Expenses
|
5.9m
USD
|
|
Net Income
|
-17.9m
USD
|
Free Cash Flow Analysis
Soliton Inc
What is Free Cash Flow?
SOLY Profitability Score
Profitability Due Diligence
Soliton Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Soliton Inc's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
SOLY Solvency Score
Solvency Due Diligence
Soliton Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Soliton Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOLY Price Targets Summary
Soliton Inc
Shareholder Return
SOLY Price
Soliton Inc
| Average Annual Return | -19.97% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -62% |
| Market Capitalization | 487.6m USD |
| Shares Outstanding | 21 190 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Soliton Inc
Country
Industry
Market Cap
Dividend Yield
Description
Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-02-19. The firm is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). The company develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It’s designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.
You don't have any saved screeners yet
